Fennec Pharmaceuticals Inc (FENC)
9.23
+0.07
(+0.76%)
USD |
NASDAQ |
Apr 26, 16:00
9.23
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Cash from Operations (TTM): -17.14M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -17.14M |
| September 30, 2023 | -19.08M |
| June 30, 2023 | -21.34M |
| March 31, 2023 | -20.78M |
| December 31, 2022 | -18.06M |
| September 30, 2022 | -14.50M |
| June 30, 2022 | -12.45M |
| March 31, 2022 | -13.48M |
| December 31, 2021 | -14.22M |
| September 30, 2021 | -14.26M |
| June 30, 2021 | -16.75M |
| March 31, 2021 | -15.44M |
| December 31, 2020 | -15.60M |
| September 30, 2020 | -13.90M |
| June 30, 2020 | -10.69M |
| March 31, 2020 | -10.33M |
| December 31, 2019 | -9.06M |
| September 30, 2019 | -10.40M |
| June 30, 2019 | -9.764M |
| March 31, 2019 | -8.578M |
| December 31, 2018 | -7.826M |
| September 30, 2018 | -6.216M |
| June 30, 2018 | -5.575M |
| March 31, 2018 | -4.693M |
| December 31, 2017 | -3.641M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.932M |
| June 30, 2017 | -2.518M |
| March 31, 2017 | -2.30M |
| December 31, 2016 | -2.124M |
| September 30, 2016 | -1.937M |
| June 30, 2016 | -1.902M |
| March 31, 2016 | -1.943M |
| December 31, 2015 | -1.862M |
| September 30, 2015 | -1.906M |
| June 30, 2015 | -1.84M |
| March 31, 2015 | -1.739M |
| December 31, 2014 | -1.699M |
| September 30, 2014 | -1.676M |
| June 30, 2014 | -1.702M |
| March 31, 2014 | -2.181M |
| December 31, 2013 | -2.21M |
| September 30, 2013 | -2.322M |
| June 30, 2013 | -2.579M |
| March 31, 2013 | -2.823M |
| December 31, 2012 | -2.994M |
| September 30, 2012 | -3.204M |
| June 30, 2012 | -3.114M |
| March 31, 2012 | -2.756M |
| December 31, 2011 | -3.226M |
| September 30, 2011 | -3.114M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-21.34M
Minimum
Jun 2023
-9.06M
Maximum
Dec 2019
-14.59M
Average
-14.26M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Pfizer Inc | 8.70B |
| OptiNose Inc | -20.53M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |